Skip to content

Dysfunctional Mitochondria in Microglia Drive Cognitive Aging and Neurodegeneration via cGAS-STING.

Jul 2026 · Neuroscience Bulletin · 0 citations · 67 references
Medicine

TL;DR

It is demonstrated that dysfunctional mitochondria in microglia act as triggers of metabolic dysregulation, cognitive aging, and neurodegeneration in adult mice, underscoring the significance of tightly regulated metabolism in age-associated neurological diseases.

View source

Similar papers

Review Open access Aug 2026

From metabolism to neurodegeneration: how microglial functional reprogramming drives neurodegenerative diseases

A microglial immunometabolic trajectory framework is proposed in which metabolic states are viewed as branching and potentially reversible determinants of cellular function rather than fixed stages of a universal disease pathway.

Qiao-Qiao Cui, Ke Zheng, Qi-Yun Liu et al. · 0 citations
Review Open access Aug 2026

Metabolic Reprogramming of Brain Microglia: Implications for Aging and Aging‐Associated Neurodegenerative Diseases

The need for integrative studies that consider microglial subsets, sex differences, disease context, and upstream molecular regulators to better understand how microglial metabolism contributes to brain health and pathology is emphasized.

Seokjo Kang, H. Goodridge · 0 citations
Review Jul 2026

Microglial immunometabolic reprogramming in Alzheimer's disease: From mitochondrial dysfunction and redox imbalance to NLRP3 inflammasome-driven neuroinflammation

A stage-dependent mitochondrial dysfunction–redox imbalance–NLRP3 inflammasome axis provides a testable stage-dependent framework for interpreting chronic, self-amplifying neuroinflammation in AD and may inform biomarker-guided, combinatorial therapeutic strategies.

Si-Yu Li, Jun-Tao Jin, Ying-Ying Liu et al. · 1 citation
Review 2026

Microglia extracellular traps (MiETs) in Neurodegeneration: Mechanisms, Evidence Gaps, and Untapped Therapeutic Promise.

This work situates MiET formation within the broader microglial functional repertoire and focuses on how ET-dominant responses may compromise homeostatic or neuroprotective roles, expanding the conceptual framework for microglial pathogenicity and inviting future mechanistic and translational research.

Lipika Sha, Sushmita Jha · 0 citations
Review Open access Jul 2026

Microglial mitophagy as an immunometabolic checkpoint in alzheimer’s disease: linking mitochondrial quality control to neuroinflammation

AD is a complex neurodegenerative disorder characterized by chronic neuroinflammation. Microglia, the brain’s resident immune cells, centrally regulate AD pathophysiology. Recent studies have highlighted microglial mitophagy as an important interface linking mitochondrial quality control to innate immune responses.Inta...

Ming-Yue Zou, Teng-Yu Zhao, Wei-Dong Wu et al. · 0 citations
Open access Jul 2026

Glycogen-Dependent Metabolic Reprogramming Regulates Microglial Activation and Dysfunction in Neurodegenerative Disease

Glycolytic inhibition of glycogenolysis blunted microglia responses to Abeta aggregates and markedly reduced Abeta uptake, confirming a functional role for glycogen metabolism in shaping microglial states and highlighting glycogen homeostasis as a potential therapeutic target for promoting Abeta clearance and preservin...

Hannah McAlister, Heather Merchant, Verity F. T. Mitchener et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.